Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Capranzano

Showing results (51-60 of 224) with videos related to

Pageof 23
Sort By:
Expert Review of Cardiovascular Therapy|September 16, 2014
Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomesGiuseppe Gargiulo, Davide Capodanno, Giovanni Longo, et al.
Expert Opinion on Pharmacotherapy|October 22, 2008
Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical developmentDominick J Angiolillo, Siva Suryadevara, Piera Capranzano, et al.
International Journal of Cardiology|April 13, 2012
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patientsDavide Capodanno, Piera Capranzano, Giuseppe Giacchi, et al.
The American Journal of Cardiology|July 9, 2014
Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterizationDaniele Giacoppo, Davide Capodanno, Piera Capranzano, et al.
Expert Review of Cardiovascular Therapy|June 15, 2019
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an updateAntonio Greco, Piera Capranzano, Marco Barbanti, et al.
International Journal of Cardiology|June 26, 2012
Increasing CHADS₂ scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleedingDavide Capodanno, Piera Capranzano, Giuseppe Giacchi, et al.
Giornale Italiano Di Cardiologia (2006)|August 29, 2017
[The new frontiers of patent foramen ovale]Maria Elena Di Salvo, Fabio Maria Santagati, Piera Capranzano, et al.
Hospital Practice (1995)|November 12, 2010
Clinical impact of enhanced inhibition of P2Y12-mediated platelet aggregation in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary interventionPiera Capranzano, Roxana Mehran, Corrado Tamburino, et al.
Thrombosis Research|September 7, 2021
Impact of direct oral anticoagulants on evolution of post-thrombotic syndromeLuigi Di Pino, Bruno Francaviglia, Marco Frazzetto, et al.
JACC. Cardiovascular Interventions|May 23, 2015
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary arteryGiuseppe Gargiulo, Giovanni Longo, Davide Capodanno, et al.
Pageof 23

Showing results (51-60 of 224) with videos related to

Sort By:
Pageof 23
Expert Review of Cardiovascular Therapy|September 16, 2014
Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomesGiuseppe Gargiulo, Davide Capodanno, Giovanni Longo, et al.
Expert Opinion on Pharmacotherapy|October 22, 2008
Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical developmentDominick J Angiolillo, Siva Suryadevara, Piera Capranzano, et al.
International Journal of Cardiology|April 13, 2012
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patientsDavide Capodanno, Piera Capranzano, Giuseppe Giacchi, et al.
The American Journal of Cardiology|July 9, 2014
Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterizationDaniele Giacoppo, Davide Capodanno, Piera Capranzano, et al.
Expert Review of Cardiovascular Therapy|June 15, 2019
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an updateAntonio Greco, Piera Capranzano, Marco Barbanti, et al.
International Journal of Cardiology|June 26, 2012
Increasing CHADS₂ scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleedingDavide Capodanno, Piera Capranzano, Giuseppe Giacchi, et al.
Giornale Italiano Di Cardiologia (2006)|August 29, 2017
[The new frontiers of patent foramen ovale]Maria Elena Di Salvo, Fabio Maria Santagati, Piera Capranzano, et al.
Hospital Practice (1995)|November 12, 2010
Clinical impact of enhanced inhibition of P2Y12-mediated platelet aggregation in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary interventionPiera Capranzano, Roxana Mehran, Corrado Tamburino, et al.
Thrombosis Research|September 7, 2021
Impact of direct oral anticoagulants on evolution of post-thrombotic syndromeLuigi Di Pino, Bruno Francaviglia, Marco Frazzetto, et al.
JACC. Cardiovascular Interventions|May 23, 2015
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary arteryGiuseppe Gargiulo, Giovanni Longo, Davide Capodanno, et al.
Pageof 23